Selera Medical

Selera Medical is a Y Combinator-backed (W24) medical device startup building MILO - minimally invasive lymphatic offloading - a one-time, catheter-based procedure that treats fluid overload in chronic heart failure. Instead of a lifelong drug regimen, Selera taps the body's lymphatic system to drain trapped fluid from the interstitial space, aiming to break the cycle of repeat hospitalizations that defines late-stage heart failure. Founded in 2023 by CEO Stacie Arechavala and CTO Kevin Bui, both former Stanford Biodesign fellows.